Blue light flexible cystoscopy with hexaminolevulinate in nonmuscleinvasive bladder cancer review of the clinical evidence and consensus statement on optimal use in the USA update 2018

Blue light flexible cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on optimal use in the USA — update 2018

01:46 EDT 25 Apr 2019 | Nature Publishing

More From BioPortfolio on "Blue light flexible cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on optimal use in the USA — update 2018"